Anti-KREMEN2抗体跨膜蛋白KREMEN2抗体

点击查看大图

产品价格： < 面议

产品型号：跨膜蛋白KREMEN2抗体

品牌：KALANG

公司名称：上海康朗生物科技有限公司

所在地：上海

发布时间：2018-07-15

浏览次数：238 次

立即询价在线咨询

产品简介

Anti-KREMEN2抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-KREMEN2抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。

产品详细信息

Rabbit Anti-KREMEN2

Cat. Number:

Anti-KREMEN2抗体KL-16813R

Quantity size:

0.2ml

Concentration:

1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

This gene encodes a high-affinity dickkopf homolog 1 (DKK1) transmembrane receptor. A similar protein in mouse functions interacts with with DKK1 to block wingless (WNT)/beta-catenin signaling. The encoded protein forms aAnti-KREMEN2抗体 ternary membrane complex with DKK1 and the WNT receptor lipoprotein receptor-related protein 6 (LRP6), and induces rapid endocytosis and removal of LRP6 from the plasma membrane. It contains extracellular kringle, WSC, and CUB domains. Alternatively spliced transcript variants encoding distinct isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]

Also known as:

Dickkopf receptor 2; KREM2_HUMAN;Anti-KREMEN2抗体KREMEN 2; Kremen protein 2; Kremen protein 2 precursor; Kremen2; Kringle containing protein marking the eye and the nose; Kringle containing transmembrane protein 2; Kringle domain containing transmembrane protein 2; Kringle domain-containing transmembrane protein 2; Kringle-containing protein marking the eye and the nose; KRM 2; KRM2; MGC10791; MGC16709.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Anti-KREMEN2抗体Sheep, .

●

Immunogen: KLH conjugated synthetic peptide derived from human KREMEN2.

●

Predicted Molecular Weight: 46kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-KREMEN2抗体
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.